Stock Track | C-MER Medical Plunges Over 10% Despite Modest Earnings Growth

Stock Track09-03

Shares of C-MER Medical Holdings Ltd. (HKG:3309) plummeted by over 10% in intraday trading on September 2, 2024, despite the company reporting modest growth in its first-half 2024 financial results.

The Hong Kong-based medical device company posted a 3.4% year-over-year increase in net income to HK$30.8 million for the first half of 2024. However, revenue declined by 2.9% to HK$922.5 million compared to the same period last year.

Despite the slight improvement in profit margin, driven by lower expenses, the market appeared to react negatively to the tepid revenue growth and the overall financial performance, which fell short of expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment